Hey there, time traveller!
This article was published 18/1/2013 (1647 days ago), so information in it may no longer be current.
The province will cover 153 new drugs through Pharmacare beginning on Monday.
Among them are many generic brands that the government expects will save it $2.9 million a year.
The new drugs include treatments for diabetes, hypertension, heart disease, colitis and Crohn’s disease.
Specific drugs include Brilinta for reducing the risk of heart attack, Mezavant for treatment of ulcerative colitis and Crohn’s disease, and Protopic for the treatment of moderate to severe eczema.
According to the Canadian Generic Pharmaceutical Association, generic drugs accounted for 65.1 per cent of prescriptions in Manitoba in 2011 – the highest use of generics in Canada, Health Minister Theresa Oswald said in a release.
Pharmacare is a universal, comprehensive prescription drug program. It covers 100 per cent of Manitobans’ eligible drug costs once an income-based deductible is reached